Medpace Holdings, Inc. (MEDP) Average P/FCF Ratio
The current p/fcf ratio for Medpace Holdings, Inc. (MEDP) is 17.94 as of Wednesday, June 17, 2026, shown against its trailing averages.
Average P/FCF Ratio Chart
MEDP P/FCF Ratio Averages
P/FCF RATIO CURRENT
17.94
P/FCF RATIO TTM
21.95
P/FCF RATIO 3Y
22.58
P/FCF RATIO 5Y
22.80
P/FCF RATIO 10Y
20.69
P/FCF RATIO 15Y
20.69
P/FCF RATIO 20Y
20.69
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle